世界のゴーシェ病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gaucher Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2505 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ゴーシェ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タイプ1（神経障害性フォーム）、タイプ2（周産期致死フォーム）、タイプ3（遅神経学的崩壊フォーム））、用途別市場規模（病院、外来手術センター、臨床研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ゴーシェ病治療の市場動向 ・企業の競争状況、市場シェア ・ゴーシェ病治療の種類別市場規模（タイプ1（神経障害性フォーム）、タイプ2（周産期致死フォーム）、タイプ3（遅神経学的崩壊フォーム）） ・ゴーシェ病治療の用途別市場規模（病院、外来手術センター、臨床研究所） ・ゴーシェ病治療の北米市場規模2016-2027（アメリカ、カナダ） ・ゴーシェ病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ゴーシェ病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ゴーシェ病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ゴーシェ病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Aptalis Pharma、Genzyme Corporation、GlaxoSmithKline (GSK)、Pfizer Inc、Shire Human Genetic Therapies、Eli Lilly and Company、Enobia Pharma Inc、Anthera Pharmaceuticals、BioMarin Pharmaceutical、MedPro Rx、Zymenex A/S） ・結論

Market Analysis and Insights: Global Gaucher Disease Treatment Market
The global Gaucher Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gaucher Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gaucher Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gaucher Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gaucher Disease Treatment market.

Global Gaucher Disease Treatment Scope and Market Size
Gaucher Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Type 1 (Neuropathic Forms)
Type 2 (Perinatal Lethal Form)
Type 3 (Slow-neurologic Decay Form)

Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinical Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Aptalis Pharma
Genzyme Corporation
GlaxoSmithKline (GSK)
Pfizer Inc
Shire Human Genetic Therapies
Eli Lilly and Company
Enobia Pharma Inc
Anthera Pharmaceuticals
GlaxoSmithKline (GSK)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gaucher Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Type 1 (Neuropathic Forms)
1.2.3 Type 2 (Perinatal Lethal Form)
1.2.4 Type 3 (Slow-neurologic Decay Form)
1.3 Market by Application
1.3.1 Global Gaucher Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinical Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gaucher Disease Treatment Market Perspective (2016-2027)
2.2 Gaucher Disease Treatment Growth Trends by Regions
2.2.1 Gaucher Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gaucher Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Gaucher Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Gaucher Disease Treatment Industry Dynamic
2.3.1 Gaucher Disease Treatment Market Trends
2.3.2 Gaucher Disease Treatment Market Drivers
2.3.3 Gaucher Disease Treatment Market Challenges
2.3.4 Gaucher Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gaucher Disease Treatment Players by Revenue
3.1.1 Global Top Gaucher Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Gaucher Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Gaucher Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gaucher Disease Treatment Revenue
3.4 Global Gaucher Disease Treatment Market Concentration Ratio
3.4.1 Global Gaucher Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gaucher Disease Treatment Revenue in 2020
3.5 Gaucher Disease Treatment Key Players Head office and Area Served
3.6 Key Players Gaucher Disease Treatment Product Solution and Service
3.7 Date of Enter into Gaucher Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gaucher Disease Treatment Breakdown Data by Type
4.1 Global Gaucher Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Gaucher Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Gaucher Disease Treatment Breakdown Data by Application
5.1 Global Gaucher Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Gaucher Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gaucher Disease Treatment Market Size (2016-2027)
6.2 North America Gaucher Disease Treatment Market Size by Type
6.2.1 North America Gaucher Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Gaucher Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Gaucher Disease Treatment Market Size by Type (2016-2027)
6.3 North America Gaucher Disease Treatment Market Size by Application
6.3.1 North America Gaucher Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Gaucher Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Gaucher Disease Treatment Market Size by Application (2016-2027)
6.4 North America Gaucher Disease Treatment Market Size by Country
6.4.1 North America Gaucher Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Gaucher Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gaucher Disease Treatment Market Size (2016-2027)
7.2 Europe Gaucher Disease Treatment Market Size by Type
7.2.1 Europe Gaucher Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Gaucher Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Gaucher Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Gaucher Disease Treatment Market Size by Application
7.3.1 Europe Gaucher Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Gaucher Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Gaucher Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Gaucher Disease Treatment Market Size by Country
7.4.1 Europe Gaucher Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Gaucher Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gaucher Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Gaucher Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Gaucher Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gaucher Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gaucher Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Gaucher Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Gaucher Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gaucher Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gaucher Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Gaucher Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Gaucher Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gaucher Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gaucher Disease Treatment Market Size (2016-2027)
9.2 Latin America Gaucher Disease Treatment Market Size by Type
9.2.1 Latin America Gaucher Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Gaucher Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Gaucher Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Gaucher Disease Treatment Market Size by Application
9.3.1 Latin America Gaucher Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Gaucher Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Gaucher Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Gaucher Disease Treatment Market Size by Country
9.4.1 Latin America Gaucher Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Gaucher Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gaucher Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Gaucher Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Gaucher Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gaucher Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gaucher Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Gaucher Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Gaucher Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gaucher Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gaucher Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Gaucher Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Gaucher Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gaucher Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Gaucher Disease Treatment Introduction
11.1.4 Abbott Revenue in Gaucher Disease Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Aptalis Pharma
11.2.1 Aptalis Pharma Company Details
11.2.2 Aptalis Pharma Business Overview
11.2.3 Aptalis Pharma Gaucher Disease Treatment Introduction
11.2.4 Aptalis Pharma Revenue in Gaucher Disease Treatment Business (2016-2021)
11.2.5 Aptalis Pharma Recent Development
11.3 Genzyme Corporation
11.3.1 Genzyme Corporation Company Details
11.3.2 Genzyme Corporation Business Overview
11.3.3 Genzyme Corporation Gaucher Disease Treatment Introduction
11.3.4 Genzyme Corporation Revenue in Gaucher Disease Treatment Business (2016-2021)
11.3.5 Genzyme Corporation Recent Development
11.4 GlaxoSmithKline (GSK)
11.4.1 GlaxoSmithKline (GSK) Company Details
11.4.2 GlaxoSmithKline (GSK) Business Overview
11.4.3 GlaxoSmithKline (GSK) Gaucher Disease Treatment Introduction
11.4.4 GlaxoSmithKline (GSK) Revenue in Gaucher Disease Treatment Business (2016-2021)
11.4.5 GlaxoSmithKline (GSK) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Gaucher Disease Treatment Introduction
11.5.4 Pfizer Inc Revenue in Gaucher Disease Treatment Business (2016-2021)
11.5.5 Pfizer Inc Recent Development
11.6 Shire Human Genetic Therapies
11.6.1 Shire Human Genetic Therapies Company Details
11.6.2 Shire Human Genetic Therapies Business Overview
11.6.3 Shire Human Genetic Therapies Gaucher Disease Treatment Introduction
11.6.4 Shire Human Genetic Therapies Revenue in Gaucher Disease Treatment Business (2016-2021)
11.6.5 Shire Human Genetic Therapies Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Gaucher Disease Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Gaucher Disease Treatment Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Enobia Pharma Inc
11.8.1 Enobia Pharma Inc Company Details
11.8.2 Enobia Pharma Inc Business Overview
11.8.3 Enobia Pharma Inc Gaucher Disease Treatment Introduction
11.8.4 Enobia Pharma Inc Revenue in Gaucher Disease Treatment Business (2016-2021)
11.8.5 Enobia Pharma Inc Recent Development
11.9 Anthera Pharmaceuticals
11.9.1 Anthera Pharmaceuticals Company Details
11.9.2 Anthera Pharmaceuticals Business Overview
11.9.3 Anthera Pharmaceuticals Gaucher Disease Treatment Introduction
11.9.4 Anthera Pharmaceuticals Revenue in Gaucher Disease Treatment Business (2016-2021)
11.9.5 Anthera Pharmaceuticals Recent Development
11.10 BioMarin Pharmaceutical
11.10.1 BioMarin Pharmaceutical Company Details
11.10.2 BioMarin Pharmaceutical Business Overview
11.10.3 BioMarin Pharmaceutical Gaucher Disease Treatment Introduction
11.10.4 BioMarin Pharmaceutical Revenue in Gaucher Disease Treatment Business (2016-2021)
11.10.5 BioMarin Pharmaceutical Recent Development
11.11 MedPro Rx
11.11.1 MedPro Rx Company Details
11.11.2 MedPro Rx Business Overview
11.11.3 MedPro Rx Gaucher Disease Treatment Introduction
11.11.4 MedPro Rx Revenue in Gaucher Disease Treatment Business (2016-2021)
11.11.5 MedPro Rx Recent Development
11.12 Zymenex A/S
11.12.1 Zymenex A/S Company Details
11.12.2 Zymenex A/S Business Overview
11.12.3 Zymenex A/S Gaucher Disease Treatment Introduction
11.12.4 Zymenex A/S Revenue in Gaucher Disease Treatment Business (2016-2021)
11.12.5 Zymenex A/S Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gaucher Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Type 1 (Neuropathic Forms)
Table 3. Key Players of Type 2 (Perinatal Lethal Form)
Table 4. Key Players of Type 3 (Slow-neurologic Decay Form)
Table 5. Global Gaucher Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gaucher Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gaucher Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gaucher Disease Treatment Market Share by Regions (2016-2021)
Table 9. Global Gaucher Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gaucher Disease Treatment Market Share by Regions (2022-2027)
Table 11. Gaucher Disease Treatment Market Trends
Table 12. Gaucher Disease Treatment Market Drivers
Table 13. Gaucher Disease Treatment Market Challenges
Table 14. Gaucher Disease Treatment Market Restraints
Table 15. Global Gaucher Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gaucher Disease Treatment Market Share by Players (2016-2021)
Table 17. Global Top Gaucher Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease Treatment as of 2020)
Table 18. Ranking of Global Top Gaucher Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gaucher Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gaucher Disease Treatment Product Solution and Service
Table 22. Date of Enter into Gaucher Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gaucher Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gaucher Disease Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Gaucher Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gaucher Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gaucher Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gaucher Disease Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Gaucher Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gaucher Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gaucher Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gaucher Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gaucher Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gaucher Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gaucher Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gaucher Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gaucher Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gaucher Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gaucher Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gaucher Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gaucher Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gaucher Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gaucher Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gaucher Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gaucher Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gaucher Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gaucher Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gaucher Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gaucher Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gaucher Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gaucher Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gaucher Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gaucher Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gaucher Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gaucher Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gaucher Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gaucher Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gaucher Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gaucher Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gaucher Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Gaucher Disease Treatment Product
Table 65. Abbott Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Aptalis Pharma Company Details
Table 68. Aptalis Pharma Business Overview
Table 69. Aptalis Pharma Gaucher Disease Treatment Product
Table 70. Aptalis Pharma Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 71. Aptalis Pharma Recent Development
Table 72. Genzyme Corporation Company Details
Table 73. Genzyme Corporation Business Overview
Table 74. Genzyme Corporation Gaucher Disease Treatment Product
Table 75. Genzyme Corporation Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 76. Genzyme Corporation Recent Development
Table 77. GlaxoSmithKline (GSK) Company Details
Table 78. GlaxoSmithKline (GSK) Business Overview
Table 79. GlaxoSmithKline (GSK) Gaucher Disease Treatment Product
Table 80. GlaxoSmithKline (GSK) Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline (GSK) Recent Development
Table 82. Pfizer Inc Company Details
Table 83. Pfizer Inc Business Overview
Table 84. Pfizer Inc Gaucher Disease Treatment Product
Table 85. Pfizer Inc Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 86. Pfizer Inc Recent Development
Table 87. Shire Human Genetic Therapies Company Details
Table 88. Shire Human Genetic Therapies Business Overview
Table 89. Shire Human Genetic Therapies Gaucher Disease Treatment Product
Table 90. Shire Human Genetic Therapies Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 91. Shire Human Genetic Therapies Recent Development
Table 92. Eli Lilly and Company Company Details
Table 93. Eli Lilly and Company Business Overview
Table 94. Eli Lilly and Company Gaucher Disease Treatment Product
Table 95. Eli Lilly and Company Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 96. Eli Lilly and Company Recent Development
Table 97. Enobia Pharma Inc Company Details
Table 98. Enobia Pharma Inc Business Overview
Table 99. Enobia Pharma Inc Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. Enobia Pharma Inc Recent Development
Table 101. Anthera Pharmaceuticals Company Details
Table 102. Anthera Pharmaceuticals Business Overview
Table 103. Anthera Pharmaceuticals Gaucher Disease Treatment Product
Table 104. Anthera Pharmaceuticals Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 105. Anthera Pharmaceuticals Recent Development
Table 106. BioMarin Pharmaceutical Company Details
Table 107. BioMarin Pharmaceutical Business Overview
Table 108. BioMarin Pharmaceutical Gaucher Disease Treatment Product
Table 109. BioMarin Pharmaceutical Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 110. BioMarin Pharmaceutical Recent Development
Table 111. MedPro Rx Company Details
Table 112. MedPro Rx Business Overview
Table 113. MedPro Rx Gaucher Disease Treatment Product
Table 114. MedPro Rx Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 115. MedPro Rx Recent Development
Table 116. Zymenex A/S Company Details
Table 117. Zymenex A/S Business Overview
Table 118. Zymenex A/S Gaucher Disease Treatment Product
Table 119. Zymenex A/S Revenue in Gaucher Disease Treatment Business (2016-2021) & (US$ Million)
Table 120. Zymenex A/S Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gaucher Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Type 1 (Neuropathic Forms) Features
Figure 3. Type 2 (Perinatal Lethal Form) Features
Figure 4. Type 3 (Slow-neurologic Decay Form) Features
Figure 5. Global Gaucher Disease Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Clinical Research Institutes Case Studies
Figure 9. Gaucher Disease Treatment Report Years Considered
Figure 10. Global Gaucher Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gaucher Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gaucher Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Gaucher Disease Treatment Market Share by Regions (2022-2027)
Figure 14. Global Gaucher Disease Treatment Market Share by Players in 2020
Figure 15. Global Top Gaucher Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gaucher Disease Treatment Revenue in 2020
Figure 17. Global Gaucher Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Gaucher Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gaucher Disease Treatment Market Share by Type (2016-2027)
Figure 21. North America Gaucher Disease Treatment Market Share by Application (2016-2027)
Figure 22. North America Gaucher Disease Treatment Market Share by Country (2016-2027)
Figure 23. United States Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gaucher Disease Treatment Market Share by Type (2016-2027)
Figure 27. Europe Gaucher Disease Treatment Market Share by Application (2016-2027)
Figure 28. Europe Gaucher Disease Treatment Market Share by Country (2016-2027)
Figure 29. Germany Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gaucher Disease Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gaucher Disease Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gaucher Disease Treatment Market Share by Region (2016-2027)
Figure 39. China Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gaucher Disease Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Gaucher Disease Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Gaucher Disease Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gaucher Disease Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gaucher Disease Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gaucher Disease Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gaucher Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 59. Aptalis Pharma Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 60. Genzyme Corporation Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline (GSK) Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 62. Pfizer Inc Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 63. Shire Human Genetic Therapies Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 65. Enobia Pharma Inc Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 66. Anthera Pharmaceuticals Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 67. BioMarin Pharmaceutical Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 68. MedPro Rx Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 69. Zymenex A/S Revenue Growth Rate in Gaucher Disease Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---